Atlas Trials

Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures

Clinical trial NCT04970212 · COMPLETED

Trial details

NCT number
NCT04970212
Sponsor
Techsomed Medical Technologies LTD
Status
COMPLETED
Study type
OBSERVATIONAL
Carcinoma, HepatocellularMetastatic Liver Cancer
Start date
2021-09-24
Primary completion
2022-10-08
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.